CELESTIAL — Celestial Biolabs Income Statement

0.000.00%

Last trade - 00:00

Consumer DefensivesMicro Cap

Annual income statement for Celestial Biolabs, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2016 March 31st	2017 March 31st	R2018 March 31st	2019 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	Interim Report	PRESS	ARS
Standards:	IAS	IAS	—	—	IAS
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	329	387	428	490	1.69
Cost of Revenue
Gross Profit	140	109	141	203	0.626
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	300	350	387	467	7.42
Operating Profit	28.5	36.9	41.3	23	-5.73
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	18.5	36.7	41.1	14	-5.81
Provision for Income Taxes
Net Income After Taxes	20.8	33.3	33.3	-0.281	-5.81
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	20.8	33.3	33.3	-0.281	-5.81
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	20.8	33.3	33.3	-0.281	-5.81
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	0.92	1.48	1.47	-0.012	-0.26
Dividends per Share